HOME >> MEDICINE >> NEWS
New compound unusually potent at blocking brain cancer growth

By determining how a class of compounds blocks signaling in cells, UCSF scientists have identified what is perhaps the most potent drug candidate yet against a highly lethal kind of brain tumor.

The compound, known as PI-103, shows unique potency against cancer cell proliferation in studies of mice with grafts of human glioma cells. Gliomas are the most common form of brain cancer, and have proven very difficult to treat.

The unique effectiveness of PI-103 stems from its ability to attack two separate steps in the series of signals that trigger the spread of cancer. The dual blockade proved to be a safe and effective inhibitor of cancer cell proliferation in mice with the human tumors, the scientists found.

The glioma research is being published online May 15 by the journal Cancer Cell. A description of the strategy used to identify the molecular level action of the inhibitors was published online by the journal Cell on April 27.

Food and Drug Administration approval five years ago of the cancer drug Gleevec marked a promising new strategy against cancer. Gleevec was the first drug on the market designed to block ubiquitous signaling molecules called protein kinases enzymes known to trigger normal cell proliferation, and in the case of cancer, the growth of tumors. Another group of kinases, called lipid kinases are now emerging as important new targets, especially PI3 alpha kinase, an enzyme often found to be overactive in brain, breast, colon and stomach cancers.

But the sheer number of related kinases 15 in the PI3 kinase family alone and uncertainty about how each acts in the body has stalled progress. Broad spectrum drugs that inhibit many related kinases inevitably cause toxicity and are poor drug candidates.

To overcome this hurdle, Kevan Shokat, PhD, a Howard Hughes Medical Institute investigator at UCSF, and Zachary Knight, a postdoctoral fellow in his lab, developed a strategy to systematically inhibit many different but r
'"/>

Contact: Wallace Ravven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
15-May-2006


Page: 1 2 3

Related medicine news :

1. New oxidation methods streamline synthesis of important compounds
2. AMPAKINE compounds a new potential treatment for respiratory depression
3. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
4. Green tea compound may be a therapy for people with rheumatoid arthritis
5. Anti-dandruff compound may help fight epilepsy
6. Depression among retired NFL players: Rates mirror the general public, but pain compounds symptoms
7. Chromium 6: A killer compound with an improbable trigger
8. New compound shows promise in halting HIV spread
9. New imaging compound might see Alzheimers earlier
10. U of M researchers discover compounds to shrink tumors
11. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New compound unusually potent blocking brain cancer growth

(Date:2/27/2015)... (PRWEB) February 27, 2015 The federal ... ) that allege use of the statin medication can ... has issued a new order pertaining discovery in the ... Bernstein Liebhard LLP comments. The Order, which was issued ... on February 25th, directs the parties to schedule certain ...
(Date:2/27/2015)... 27, 2015 On February 24 2015, Harper’s ... Botox ,” that details the development of RT001, a ... its way through FDA trials. For those afraid of needles, ... very attractive. Of course, if the drug ultimately gets FDA ... physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, the ...
(Date:2/27/2015)... The winter season is here, and with it ... grows, it can be harmful to the home and to ... of mold growth with the help of Enviro-Test. Enviro-Test, the ... the best ways to prevent mold during the winter months. ... for mold to thrive. Mold must be removed properly, otherwise ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Florida Hospital ... The Guidelines - Stroke Gold Plus hospital. In order ... 85-percent or higher adherence to all Get With The ... more consecutive 12-month intervals and achieved 75-percent or higher ... - Stroke Quality Measures. These are reporting initiatives to ...
(Date:2/27/2015)... The Nashville periodontist office, Advanced ... rising freshmen undergraduate students. , The Advanced Institute for ... many periodontal procedures such as dental implants , ... . In honor of their 25th anniversary, AIOH has ... freshmen undergraduate students. , Students interested in the ...
Breaking Medicine News(10 mins):Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2
(Date:2/26/2015)... 2015  AbbVie (NYSE: ABBV ) ... its neuroscience and oncology development programs have been ... American Academy of Neurology annual meeting in ... The accepted abstracts feature results from studies evaluating ... treatments in AbbVie,s pipeline. Presentations will include Phase ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... fourth quarter and full year 2014 financial results after the ... conjunction with the release, the Company will host a conference ... Time on Thursday, March 5, 2015 to ... Interested parties may access the live conference call ...
(Date:2/26/2015)... -- Mail-service and specialty pharmacies will save ... plans $23.3 billion over the next decade, according ... Association (PCMA). "Home delivery of traditional ... ways to reduce health costs," said PCMA President ... resist efforts to restrict these cost-saving tools." ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
Cached News: